|
Rakityanskaya I.A., Ryabova T.S., Kalashnikova A.A.
Effect of alloferon on the cytotoxic activity of NK cells in patients with chronic Epstein-Barr virus infection
|
№1 / 2022
|
|
Kryshen K.L., Volok V.P., Shustova E.Yu., Shipunov G.A., Zinchenko A.V., Samsonov M.Yu., Filon O.V., Shipaeva E.V.
Antiviral activity of favipiravir against novel delta and omicron SARS-CoV-2 variants
|
№1 / 2022
|
|
Shchipeleva I.A., Kretenchuk O.F., Korshenko V.A., Markovskaya E.I.
Current status and prospects for specific plague prevention
|
№1 / 2022
|
|
Karpovich G.S., Kuimova I.V., Serova Yu.S.
СOVID-19 as a probable trigger factor for autoimmune diseases in children
|
№1 / 2022
|
|
Matievskaya N.V., Volosach O.S., Kuzmich I.A.
Pseudomonas aeruginosa infection in inpatients of different profiles: clinical and microbiological aspects
|
№1 / 2022
|
|
Kovalev D.A., Kuznetsova I.V., Zhirov A.M., Serdyuk N.S., Zhilchenko E.B., Ponomarenko D.G., Vodopyanov A.S., Vodopyanov S.O., Kulichenko A.N.
Genetic typing of Brucella melitensis strains on the basis of variability analysis of INDEL loci
|
№1 / 2022
|
|
Ayugin N.I., Zarva I.D., Gavrilova T.A., Khakimova M.I., Botvinkin A.D.
Use of GIS technologies to analyze the spread of enteroviral infection in the urban environment
|
№1 / 2022
|
|
Bykov I.P., Sergeev A.G., Mishchenko V.A., Vyalykh I.V., Toporkova M.G., Vyatkina L.G., Makhorina T.V.
Clinical forms of tick-borne viral encephalitis in persons with co-infection
|
№1 / 2022
|
|
Davidova N.G., Golubkova A.A., Platonova T.A.
Strategic directions for measles infection control in healthcare facilities (according to the analysis of the outbreak in a children hospital)
|
№1 / 2022
|
|
Omarova Kh.G., Makashova V.V., Ponezheva Zh.B.
The features of the course of HBV infection during antiviral therapy
|
№1 / 2022
|
|
Volkova S.B., Podymova A.S.
Demographic and clinical characteristics of patients with new-onset HIV/CHC coinfection with the known HCV genotype
|
№1 / 2022
|
|
Stepanova E.V., Leonova O.N., Buzunova S.A.
Analysis of the established disability group in HIV-infected patients
|
№1 / 2022
|